查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區腦脊髓液管理市場預測至 2030 年 - 區域分析 - 按產品（腦脊髓液分流器和腦脊髓液引流系統）和最終用戶（醫院、診所、門診手術中心等）
市場調查報告書
商品編碼
1463658

亞太地區腦脊髓液管理市場預測至 2030 年 - 區域分析 - 按產品（腦脊髓液分流器和腦脊髓液引流系統）和最終用戶（醫院、診所、門診手術中心等）

Asia Pacific Cerebrospinal Fluid Management Market Forecast to 2030 - Regional Analysis - by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)
出版日期: | 出版商: The Insight Partners | 英文 82 Pages | 訂單完成後即時交付

價格

2022年亞太地區腦脊髓液管理市值為3.8953億美元，預計2030年將達6.1354億美元；預計2022年至2030年CAGR為5.8%。

神經系統疾病治療中對腦脊髓液管理的日益關注推動了亞太地區腦脊髓液管理市場的發展

腦脊髓液參數作為成年患者神經系統疾病的生物標記被廣泛評估。腦脊髓液中循環的 microRNA 是一類有前景的生物標記物，可用於診斷各種神經系統疾病。帕金森氏症 (PD)、阿茲海默症 (AD)、癲癇和癲癇等神經系統疾病通常會導致腦脊髓液參數改變。根據《自然》雜誌發表的一篇文章，與正常人相比，被診斷為 PD 的患者中發現 76 種腦脊髓液蛋白在結構上發生了變化。該研究還表明，這些腦脊髓液蛋白可用作診斷或治療該疾病的生物標記。 PD 是一種與認知障礙和運動功能喪失相關的神經退化性疾病。根據世界衛生組織 (WHO) 2022 年發布的報告，帕金森氏症的盛行率在過去 25 年裡加倍，影響了全球約 1% 的 60 歲以上人口。同樣，患有癲癇發作或癲癇持續狀態的患者的一些腦脊髓液參數（例如蛋白質和乳酸水平）也會發生變化。因此，利用腦脊髓液參數治療癲癇發作或癲癇的各種研發活動正在進行中。此外，儘管市場上有各種使用CSF檢測阿茲海默症的CSF測定法，但對用於檢測和治療目的的生物標記的需求尚未得到滿足。隨著阿茲海默症和帕金森氏症病例的增加，對腦脊髓液管理設備的需求也隨之增加，因為腦脊髓液漏的病例可能會增加。因此，神經系統疾病盛行率的上升正在推動使用腦脊髓液管理產品治療這些疾病的研發活動。

亞太地區腦脊髓液管理市場概況

亞太地區腦脊髓液管理分為中國、日本、印度、澳洲、韓國和亞太其他地區。亞太地區是全球腦脊髓液管理成長最快的市場。該地區腦脊髓液管理市場的成長歸因於老年人口的成長、對先進醫療設備的需求以及提供有效治療的醫療基礎設施的增加。

亞太地區腦脊髓液管理市場收入及 2030 年預測（百萬美元）

亞太地區腦脊髓液管理市場區隔

亞太地區腦脊髓液管理市場分為產品、最終用戶和國家。

根據產品，亞太地區腦脊髓液管理市場分為腦脊髓液分流器和腦脊髓液引流系統。 2022 年，CCS 分流器細分市場將佔據更大的市場。

根據最終用戶，亞太地區腦脊髓液管理市場分為醫院、診所、門診手術中心等。 2022 年，醫院細分市場佔據最大市場佔有率。

依國家/地區分類，亞太地區腦脊髓液管理市場分為中國、日本、印度、澳洲、韓國和亞太地區其他地區。 2022年，中國在亞太腦脊髓液管理市場佔有率中佔據主導地位。

B. Braun SE、Integra LifeSciences Holdings Corp、Medtronic Plc、Natus Medical Inc 和 Spiegelberg GmbH & Co KG 是亞太地區腦脊髓液管理市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 重要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：亞太地區腦脊髓液管理市場格局

  • 概述
  • 亞太地區 PEST 分析

第 5 章：亞太地區腦脊髓液管理市場 - 主要產業動態

  • 市場促進因素
    • 腦脊髓液漏病例增加
    • 政府為應對與 CSF 相關的日益成長的挑戰而採取的舉措
  • 市場限制
    • 故障和故障的風險
  • 市場機會
    • 在神經系統疾病治療中越來越關注腦脊髓液管理
  • 未來的趨勢
    • 智慧型腦脊髓液分流器的開發
  • 影響分析：

第 6 章：腦脊髓液管理市場 - 亞太地區市場分析

  • 亞太地區腦脊髓液管理市場收入，2022 - 2030

第 7 章：亞太地區腦脊髓液管理市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年和 2030 年亞太地區腦脊髓液管理市場收入佔有率（按產品）（%）
  • 腦脊髓液分流術
  • 腦脊髓液引流系統

第 8 章：亞太地區腦脊髓液管理市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年亞太地區腦脊髓液管理市場收入佔有率（按最終用戶分類）（%）
  • 醫院
  • 診所
  • 門診手術中心
  • 其他

第 9 章：亞太地區腦脊髓液管理市場 - 國家分析

  • 概述
      • 亞太地區腦脊髓液管理市場（依國家）
      • 中國
      • 日本
      • 印度
      • 澳洲
      • 韓國
      • 亞太地區其他地區

第 10 章：亞太地區腦脊髓液管理市場 - 產業格局

  • 概述
  • 2020-2023 年亞太地區腦脊髓液管理市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 11 章：公司簡介

  • Medtronic Plc
  • Integra LifeSciences Holdings Corp
  • B. Braun SE
  • Natus Medical Inc
  • Spiegelberg GmbH & Co KG

第 12 章：附錄

Product Code: TIPRE00028018

The Asia Pacific cerebrospinal fluid management market was valued at US$ 389.53 million in 2022 and is expected to reach US$ 613.54 million by 2030; it is estimated to grow at a CAGR of 5.8% from 2022 to 2030.

Increasing Focus on CSF Management in Neurological Disease Treatments Fuels the Asia Pacific Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson's Disease (PD), Alzheimer's Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer's disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer's disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

Asia Pacific Cerebrospinal Fluid Management Market Overview

The Asia Pacific cerebrospinal fluid management is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is the fastest-growing market for cerebrospinal fluid management in global scenario. The cerebrospinal fluid management market growth in this region is attributed to growing geriatric population, demand for advanced medical devices, and increasing healthcare infrastructures offering efficient treatments.

Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)

Asia Pacific Cerebrospinal Fluid Management Market Segmentation

The Asia Pacific cerebrospinal fluid management market is segmented into product, end user and country.

Based on product, the Asia Pacific cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.

Based on end user, the Asia Pacific cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.

Based on country, the Asia Pacific cerebrospinal fluid management market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific cerebrospinal fluid management market share in 2022.

B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, Natus Medical Inc, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the Asia Pacific cerebrospinal fluid management market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Cerebrospinal Fluid Management Market Landscape

  • 4.1 Overview
  • 4.2 Asia Pacific PEST Analysis

5. Asia Pacific Cerebrospinal Fluid Management Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
    • 5.1.2 Government Initiatives for Addressing Growing Challenges Associated with CSF
  • 5.2 Market Restraints
    • 5.2.1 Risk of Failure and Malfunctioning
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
  • 5.4 Future Trends
    • 5.4.1 Development of Smart Cerebrospinal Fluid Shunts
  • 5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - Asia Pacific Market Analysis

  • 6.1 Asia Pacific Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 CSF Shunts
    • 7.3.1 Overview
    • 7.3.2 CSF Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Ventriculoperitoneal Shunts
      • 7.3.3.1 Overview
      • 7.3.3.2 Ventriculoperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Ventriculoatrial Shunts
      • 7.3.4.1 Overview
      • 7.3.4.2 Ventriculoatrial Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Ventriculopleural Shunts
      • 7.3.5.1 Overview
      • 7.3.5.2 Ventriculopleural Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Lumboperitoneal Shunts
      • 7.3.6.1 Overview
      • 7.3.6.2 Lumboperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 CSF Drainage Systems
    • 7.4.1 Overview
    • 7.4.2 CSF Drainage Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 External Ventricular Drainage (EVD) Systems
      • 7.4.3.1 Overview
      • 7.4.3.2 External Ventricular Drainage (EVD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Lumbar Drainage (LD) Systems
      • 7.4.4.1 Overview
      • 7.4.4.2 Lumbar Drainage (LD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinics
    • 8.4.1 Overview
    • 8.4.2 Clinics: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Ambulatory Surgical Centers
    • 8.5.1 Overview
    • 8.5.2 Ambulatory Surgical Centers: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Cerebrospinal Fluid Management Market - Country Analysis

  • 9.1 Overview
      • 9.1.1.1 Asia Pacific Cerebrospinal Fluid Management Market, by Country
      • 9.1.1.2 China
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.2.3 China: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.2.3.1 China: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.2.3.2 China: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.2.4 China: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.3 Japan
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.3.3 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.3.3.1 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.3.3.2 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.3.4 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.4 India
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.4.3 India: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.4.3.1 India: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.4.3.2 India: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.4.4 India: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.5 Australia
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.5.3 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.5.3.1 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.5.3.2 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.5.4 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.6 South Korea
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.6.3 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.6.3.1 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.6.3.2 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.6.4 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.1.1.7 Rest of Asia Pacific
        • 9.1.1.7.1 Overview
        • 9.1.1.7.2 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.1.7.3 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.1.1.7.3.1 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.1.7.3.2 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.1.7.4 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by End User

10. Asia Pacific Cerebrospinal Fluid Management Market -Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market, 2020-2023
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Medtronic Plc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Integra LifeSciences Holdings Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 B. Braun SE
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Natus Medical Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Spiegelberg GmbH & Co KG
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Cerebrospinal Fluid Management Market Segmentation
  • Table 2. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 4. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 5. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 6. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 7. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 8. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 9. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 10. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 11. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 12. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 13. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 15. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 16. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 17. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 18. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 19. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 20. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 21. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 22. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 23. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 24. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 25. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 26. Recent Inorganic Growth Strategies in the Asia Pacific Cerebrospinal Fluid Management Market
  • Table 27. Recent Organic Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market
  • Table 28. Glossary of Terms, Asia Pacific Cerebrospinal Fluid Management Market

List Of Figures

  • Figure 1. Asia Pacific Cerebrospinal Fluid Management Market Segmentation, By Country
  • Figure 2. Asia Pacific - PEST Analysis
  • Figure 3. Asia Pacific Cerebrospinal Fluid Management Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Asia Pacific Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. Asia Pacific Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 - 2030
  • Figure 7. Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. CSF Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Ventriculoperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Ventriculoatrial Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Ventriculopleural Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Lumboperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. CSF Drainage Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. External Ventricular Drainage (EVD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Lumbar Drainage (LD) Systems: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 17. Hospitals: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Clinics: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Ambulatory Surgical Centers: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: Asia Pacific Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Asia Pacific Cerebrospinal Fluid Management Market, by Key Country- Revenue (2022) ($Mn)
  • Figure 22. Asia Pacific Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 23. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market, 2020-2023